Global API Drug Development Service 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082411669

Publication Date:

August 19, 2024

Pages:

135

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global API Drug Development Service market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global API Drug Development Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global API Drug Development Service market size and forecasts, in consumption value ($ Million), 2019-2030
Global API Drug Development Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global API Drug Development Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global API Drug Development Service market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for API Drug Development Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global API Drug Development Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
API Drug Development Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
API Drug Development Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Captive Product Development Service
Commercial Product Development Service
麻豆原创 segment by Application
Small Biotechs Companies
Large Pharmaceutical Organizations
麻豆原创 segment by players, this report covers
Lonza
Patheon
Catalent
Carbogen Amcis
Sterling Pharma Solutions
Cambrex
CordenPharma
Eurofins Scientific
Malvern Panalytical
Almac
Pfizer
Axplora
Aptuit
Porton
Pharmaron Beijing
Shanghai Haoyuan Chemexpress
Stapharma
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe API Drug Development Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of API Drug Development Service, with revenue, gross margin, and global market share of API Drug Development Service from 2019 to 2024.
Chapter 3, the API Drug Development Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and API Drug Development Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of API Drug Development Service.
Chapter 13, to describe API Drug Development Service research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global API Drug Development Service Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Captive Product Development Service
1.3.3 Commercial Product Development Service
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global API Drug Development Service Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Small Biotechs Companies
1.4.3 Large Pharmaceutical Organizations
1.5 Global API Drug Development Service 麻豆原创 Size & Forecast
1.5.1 Global API Drug Development Service Consumption Value (2019 & 2023 & 2030)
1.5.2 Global API Drug Development Service Sales Quantity (2019-2030)
1.5.3 Global API Drug Development Service Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza API Drug Development Service Product and Services
2.1.4 Lonza API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Lonza Recent Developments/Updates
2.2 Patheon
2.2.1 Patheon Details
2.2.2 Patheon Major Business
2.2.3 Patheon API Drug Development Service Product and Services
2.2.4 Patheon API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Patheon Recent Developments/Updates
2.3 Catalent
2.3.1 Catalent Details
2.3.2 Catalent Major Business
2.3.3 Catalent API Drug Development Service Product and Services
2.3.4 Catalent API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Catalent Recent Developments/Updates
2.4 Carbogen Amcis
2.4.1 Carbogen Amcis Details
2.4.2 Carbogen Amcis Major Business
2.4.3 Carbogen Amcis API Drug Development Service Product and Services
2.4.4 Carbogen Amcis API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Carbogen Amcis Recent Developments/Updates
2.5 Sterling Pharma Solutions
2.5.1 Sterling Pharma Solutions Details
2.5.2 Sterling Pharma Solutions Major Business
2.5.3 Sterling Pharma Solutions API Drug Development Service Product and Services
2.5.4 Sterling Pharma Solutions API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Sterling Pharma Solutions Recent Developments/Updates
2.6 Cambrex
2.6.1 Cambrex Details
2.6.2 Cambrex Major Business
2.6.3 Cambrex API Drug Development Service Product and Services
2.6.4 Cambrex API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Cambrex Recent Developments/Updates
2.7 CordenPharma
2.7.1 CordenPharma Details
2.7.2 CordenPharma Major Business
2.7.3 CordenPharma API Drug Development Service Product and Services
2.7.4 CordenPharma API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 CordenPharma Recent Developments/Updates
2.8 Eurofins Scientific
2.8.1 Eurofins Scientific Details
2.8.2 Eurofins Scientific Major Business
2.8.3 Eurofins Scientific API Drug Development Service Product and Services
2.8.4 Eurofins Scientific API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Eurofins Scientific Recent Developments/Updates
2.9 Malvern Panalytical
2.9.1 Malvern Panalytical Details
2.9.2 Malvern Panalytical Major Business
2.9.3 Malvern Panalytical API Drug Development Service Product and Services
2.9.4 Malvern Panalytical API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Malvern Panalytical Recent Developments/Updates
2.10 Almac
2.10.1 Almac Details
2.10.2 Almac Major Business
2.10.3 Almac API Drug Development Service Product and Services
2.10.4 Almac API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Almac Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer API Drug Development Service Product and Services
2.11.4 Pfizer API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Pfizer Recent Developments/Updates
2.12 Axplora
2.12.1 Axplora Details
2.12.2 Axplora Major Business
2.12.3 Axplora API Drug Development Service Product and Services
2.12.4 Axplora API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Axplora Recent Developments/Updates
2.13 Aptuit
2.13.1 Aptuit Details
2.13.2 Aptuit Major Business
2.13.3 Aptuit API Drug Development Service Product and Services
2.13.4 Aptuit API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Aptuit Recent Developments/Updates
2.14 Porton
2.14.1 Porton Details
2.14.2 Porton Major Business
2.14.3 Porton API Drug Development Service Product and Services
2.14.4 Porton API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Porton Recent Developments/Updates
2.15 Pharmaron Beijing
2.15.1 Pharmaron Beijing Details
2.15.2 Pharmaron Beijing Major Business
2.15.3 Pharmaron Beijing API Drug Development Service Product and Services
2.15.4 Pharmaron Beijing API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Pharmaron Beijing Recent Developments/Updates
2.16 Shanghai Haoyuan Chemexpress
2.16.1 Shanghai Haoyuan Chemexpress Details
2.16.2 Shanghai Haoyuan Chemexpress Major Business
2.16.3 Shanghai Haoyuan Chemexpress API Drug Development Service Product and Services
2.16.4 Shanghai Haoyuan Chemexpress API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates
2.17 Stapharma
2.17.1 Stapharma Details
2.17.2 Stapharma Major Business
2.17.3 Stapharma API Drug Development Service Product and Services
2.17.4 Stapharma API Drug Development Service Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Stapharma Recent Developments/Updates
3 Competitive Environment: API Drug Development Service by Manufacturer
3.1 Global API Drug Development Service Sales Quantity by Manufacturer (2019-2024)
3.2 Global API Drug Development Service Revenue by Manufacturer (2019-2024)
3.3 Global API Drug Development Service Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of API Drug Development Service by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 API Drug Development Service Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 API Drug Development Service Manufacturer 麻豆原创 Share in 2023
3.5 API Drug Development Service 麻豆原创: Overall Company Footprint Analysis
3.5.1 API Drug Development Service 麻豆原创: Region Footprint
3.5.2 API Drug Development Service 麻豆原创: Company Product Type Footprint
3.5.3 API Drug Development Service 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global API Drug Development Service 麻豆原创 Size by Region
4.1.1 Global API Drug Development Service Sales Quantity by Region (2019-2030)
4.1.2 Global API Drug Development Service Consumption Value by Region (2019-2030)
4.1.3 Global API Drug Development Service Average Price by Region (2019-2030)
4.2 North America API Drug Development Service Consumption Value (2019-2030)
4.3 Europe API Drug Development Service Consumption Value (2019-2030)
4.4 Asia-Pacific API Drug Development Service Consumption Value (2019-2030)
4.5 South America API Drug Development Service Consumption Value (2019-2030)
4.6 Middle East & Africa API Drug Development Service Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global API Drug Development Service Sales Quantity by Type (2019-2030)
5.2 Global API Drug Development Service Consumption Value by Type (2019-2030)
5.3 Global API Drug Development Service Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global API Drug Development Service Sales Quantity by Application (2019-2030)
6.2 Global API Drug Development Service Consumption Value by Application (2019-2030)
6.3 Global API Drug Development Service Average Price by Application (2019-2030)
7 North America
7.1 North America API Drug Development Service Sales Quantity by Type (2019-2030)
7.2 North America API Drug Development Service Sales Quantity by Application (2019-2030)
7.3 North America API Drug Development Service 麻豆原创 Size by Country
7.3.1 North America API Drug Development Service Sales Quantity by Country (2019-2030)
7.3.2 North America API Drug Development Service Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe API Drug Development Service Sales Quantity by Type (2019-2030)
8.2 Europe API Drug Development Service Sales Quantity by Application (2019-2030)
8.3 Europe API Drug Development Service 麻豆原创 Size by Country
8.3.1 Europe API Drug Development Service Sales Quantity by Country (2019-2030)
8.3.2 Europe API Drug Development Service Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific API Drug Development Service Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific API Drug Development Service Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific API Drug Development Service 麻豆原创 Size by Region
9.3.1 Asia-Pacific API Drug Development Service Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific API Drug Development Service Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America API Drug Development Service Sales Quantity by Type (2019-2030)
10.2 South America API Drug Development Service Sales Quantity by Application (2019-2030)
10.3 South America API Drug Development Service 麻豆原创 Size by Country
10.3.1 South America API Drug Development Service Sales Quantity by Country (2019-2030)
10.3.2 South America API Drug Development Service Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa API Drug Development Service Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa API Drug Development Service Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa API Drug Development Service 麻豆原创 Size by Country
11.3.1 Middle East & Africa API Drug Development Service Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa API Drug Development Service Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 API Drug Development Service 麻豆原创 Drivers
12.2 API Drug Development Service 麻豆原创 Restraints
12.3 API Drug Development Service Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of API Drug Development Service and Key Manufacturers
13.2 Manufacturing Costs Percentage of API Drug Development Service
13.3 API Drug Development Service Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 API Drug Development Service Typical Distributors
14.3 API Drug Development Service Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Lonza
Patheon
Catalent
Carbogen Amcis
Sterling Pharma Solutions
Cambrex
CordenPharma
Eurofins Scientific
Malvern Panalytical
Almac
Pfizer
Axplora
Aptuit
Porton
Pharmaron Beijing
Shanghai Haoyuan Chemexpress
Stapharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.